A Proposed Role for the Immune System in the Pathogenesis of Hepatitis B Virus Induced Liver Disease

References

• Melnick J. L., Dreesman G. R., Hollinger F. B. Viral hepatitis. Sci. Am. 1977; 44: 237, (1)
   Google Scholar
• Barker L. F., Shulman W. R., Murray R., Hirschman R. J., Ratner F., Diefenback W. C. L., Geller H. M. Transmission of serum hepatitis. J. Am. Med. Assoc 1970; 211: 1509
   PubMed Web of Science ®Google Scholar
• Le Bouvier G. L. The heterogeneity of Australia antigen. J. Infect. Dis. 1971; 123: 671
   PubMed Web of Science ®Google Scholar
• Krugman S., Giles J. K. Viral hepatitis: new light on an old disease. J. Am. Med. Assoc 1970; 212: 1019
   PubMed Web of Science ®Google Scholar
• Blumberg B. S., Sutnick A. I., London W. T. Australia antigen as a hepatitis virus. Variation in host response. Am. J. Med. 1970; 48: 1
   PubMed Web of Science ®Google Scholar
• Dudley F. J., Fox R. A., Sherlock S. Relationship of hepatitis associated antigen (H.A.A.) to acute and chronic liver injury. Lancet 1971; 12
   Google Scholar
• Dudley F. J., Fox R. A., Sherlock S. Cellular immunity and hepatitis-associated Australia antigen liver disease. Lancet 1972; 1: 723
   PubMed Web of Science ®Google Scholar
• Dumble L. J., MacKay I. R. HLA and chronic active hepatitis. (CAH), Digestion 1976; 15: 254
   Google Scholar
• Bach J. F., Zingraff J., Descamps B., Naret C., Jungers P. HL-Al8 phenotypes and HBs antigenemia in hemodialysis patients. Lancet 1975; 11: 707
   Google Scholar
• Levo Y. Extrahepatic manifestations of hepatitis B virus infection. Isr. J. Med. Sci. 1979; 15: 726
   Google Scholar
• Gocke D. J. Extrahepatic manifestations of viral hepatitis. Am. J. Med. Sci. 1975; 270: 49
   PubMedGoogle Scholar
• Chisari F. V., Routenberg J. A., Anderson D. S., Edgington T. S. Cellular immune reactivity in hepatitis B virus-induced liver disease in viral hepatitis. Viral Hepatitis, G. W. Vyas, S. W. Cohen, R. Schmid. Franklin Press. 1978; 245
   Google Scholar
• Meyer Zum Buschenfelde K. H., Hopf U. Studies of the pathogenesis of experimental chronic active hepatitis in rabbits. I. Induction of the disease and protective effect of allogeneic liver specific proteins. Br. J. Exp. Pathol. 1974; 55: 498
   PubMedGoogle Scholar
• Hopf U., Meyer Zum Buschenfelde K. H., Freudenberg J. Liver specific antigens of different species. II. Localization of a membrane antigen at cell surface of isolated hepatocytes. Clin Exp. Immunol. 1974; 16: 117
   PubMed Web of Science ®Google Scholar
• Good R. A., Page A. R. Fatal complications of virus hepatitis in two patients with agammaglobulinemia. Am. J. Med. 1960; 29: 804
   PubMed Web of Science ®Google Scholar
• Zinkernagel R. M., Doherty P. C. Restriction of in vitro T cell mediated cytotoxicity in lymphocyte choriomeningitis within a synergeneic or semi-allogeneic system. Nature (London) 1974; 248: 702
   Google Scholar
• Pfizemaier K., Trostman H., Rollinghoff M., Wagner H. Cell mediated immunity in lymphocytic choriomeningitis I. The specificity of cytotoxic lymphocytes. Z. Immu. Unit. Acts. For. Sen. 1976; 151: 224
   Google Scholar
• Eddleston A. L. W. F. Lymphocyte cytotoxicity to isolated hepatocytes in active chronic hepatitis. The role of T and B cells. Chronic Hepatitis Int. Symp. Montecatini 1975; 117
   Google Scholar
• Chisari F. V., Bieber M. S., Josepho C. A., Xavier C., Anderson D. S. Functional properties of lymphocyte subpopulations in hepatitis B virus infection II. Cytotoxic effector cell killing of targets which naturally express hepatitis B surface antigen and liver specific lipoprotein. J. Immunol.
   Google Scholar
• Kakumu S., Hara T., Goku H., Sakamoto N. Lymphocyte cytotoxicity against Chang liver cells in chronic active hepatitis. Cell. Immunol. 1978; 36: 46
   PubMedGoogle Scholar
• Hodgson H. J. F., Wands J. R., Isselbacher K. J. Alteration in suppressor cell activity in chronic active hepatitis. Proc. Natl. Acad. Sci. 1978; 75: 1549
   PubMedGoogle Scholar
• Chisari F. V., Castle K. L., Xavier C., Anderson D. S. Functional properties of lymphocyte subpopulations in hepatitis B virus infection. I. Suppressor cell control of T lymphocyte responsiveness. J. Immunol. 1981; 126: 38
   PubMed Web of Science ®Google Scholar
• Tavassoli H., Kawanishi H. Serum factors inhibition of lymphocyte proliferation and suppressor T cell function in alcoholic and chronic active liver disease. Gastroenterology 1978; 75: 990
   Google Scholar
• Mogensen S. C. Role of macrophages in natural resistance to virus injections. Microbiol. Rev. 1979; 43: 1
   PubMedGoogle Scholar
• Chisari F. V., Gealy W. J., Edgington T. S. Recovery of soluble sheep erythrocyte receptor from the T lymphocyte surface by proteolytic cleavage. J. Immunol. 1977; 118: 1138
   PubMed Web of Science ®Google Scholar
• Moretta L., Webb S. R., Grossi C. E., Lydyard P. M., Cooper D. M. Functional analysis of two human T cell subpopulations: help and suppression of B cell responses by T cells bearing receptor for IgM and IgG. J. Exp. Med. 1977; 146: 184
   PubMed Web of Science ®Google Scholar
• Doherty P. C., Solert D., Knowles B. B. H-2 gene expression is required for T cell-mediated lysis of virus-infected target cells. Nature 1977; 266: 361
   PubMedGoogle Scholar
• Doherty P. C., Gotze D., Trinchieri G., Zinkernagel R. M. Models for recognition of virally modified cells by immune thymus-derived lymphocytes. Immunogenetics 1976; 3: 517
   Google Scholar
• Kongshaven P. A. L., Hawkins D., Sinister J. The biology of the immune response. Clinical Immunology, S. O. Freedman, P. Gold. Harper & Row, Maryland 1976; 1
   Google Scholar
• Nelson D. L., Bundy B. M., Pitchon H. E., Blaese R. M., Strober W. The effector cells in human peripheral blood mediating mitogen induced cellular cytotoxicity and antibody dependent cellular cytotoxicity. J. Immunol. 1976; 117: 1472
   PubMed Web of Science ®Google Scholar
• Levy G. A., Edgington T. S. Lymphocyte collaboration is required for the generation of procoagulant activity. J. Exp. Med. 1980; 151: 1232
   PubMed Web of Science ®Google Scholar
• Sabesin S. M., Koff R. S. Pathogenesis of experimental viral hepatitis. N. Engl. J. Med. 1974; 290: 944
   Google Scholar
• Dehoratius R. J., Strickland R. G., Williams R. C. T and B lymphocytes in acute and chronic hepatitis. Clin. Immunol. Immunopathol. 1974; 2: 353
   PubMedGoogle Scholar
• Chisari F. V., Routenberg J. A., Edgington T. S. Mechanisms responsible for defective human T lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections. J. Clin. Invest. 1976; 57: 1227
   PubMedGoogle Scholar
• Miller D. J., Duyer J. M., Klatskin G. Identification of lymphocytes in percutaneous liver biopsy cores. Gastroenterology 1977; 72: 1199
   PubMedGoogle Scholar
• Colombo M., Vernace S. J., Paronetto F. T and B lymphocytes in patients with chronic active hepatitis. Clin. Exp. Immunol. 1977; 30: 4
   PubMedGoogle Scholar
• Chisari F. V., Routenberg J. A., Fiala M., Edgington T. S. Extrinsic modulation of human T-lymphocyte E rosette function associated with prolonged hepatocellular injury after viral hepatitis. J. Clin. Invest. 1977; 59: 134
   PubMed Web of Science ®Google Scholar
• Edgington T. S., Chisari F. V. Immunologic aspects of hepatitis B virus infection. Am. J. Med. Set 1975; 270(2)213
   Google Scholar
• Agarwal S. S., Blumberg B. B., Gerstley B. J. S., London W. T., Millman I., Sutmek A. I., Loeb L. A. Lymphocyte transformation and hepatitis. I. Impairment of thymidine incorporation and DNA polymerase activity. Proc. Soc. Exp. Biol. Med. 1971; 137: 1498
   PubMedGoogle Scholar
• Lee W. M., Reed W. P., Mitchell C. G., Galbraith R. M., Eddleston A. L. W. F., Zuckerman A. J., Williams R. Cellular and humoral immunity to hepatitis B surface antigen in active chronic hepatitis. Br. Med. J. 1975; 1: 705
   PubMed Web of Science ®Google Scholar
• Lee W. M., Reed W. D., Osman C. G., Vahrman J., Zuckerman A. J., Eddleston A. L. W. F., Williams R. Immune responses to the hepatitis B surface antigen and liver specific lipoprotein in acute type B hepatitis. Gut 1977; 18: 250
   PubMedGoogle Scholar
• Dudley F. J., Giustino V., Sherlock S. Cell mediated immunity in patients positive for hepatitis associated antigen. Br. Med. J. 1972; 4: 754
   PubMedGoogle Scholar
• Tong M. J., Wallace A. M., Peters R. L., Reynolds T. B. Lymphocyte stimulation in hepatitis B infections. N. Engl. J. Med. 1975; 293: 318
   PubMedGoogle Scholar
• Ibrahim A. B., Vyas G. N., Perkins H. A. Immune response to hepatitis B surface antigen. Infect. Immun. 1975; 11: 137
   PubMedGoogle Scholar
• Miller J., Smith M. G. M., Mitchell C. G., Reed W. D., Eddleston A. L. W. F., Williams R. Cell mediated immunity to a liver specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet. 1972; 2: 296
   PubMedGoogle Scholar
• Gershon R. K. T cell control of antibody production. Contemporary Topics in Immunology, M. D. Cooper, N. L. Warner. Plenum Press, New York 1974; Vol. 3: 1
   Google Scholar
• Gershon R. K., Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 1970; 18: 723
   PubMed Web of Science ®Google Scholar
• Ha T. Y., Waksman B. H. Role of the thymus in tolerance X. Suppressor activity of antigen-stimulated rat thymocytes transferred to normal recipients. J. Immunol. 1973; 110: 1290
   PubMedGoogle Scholar
• Miller K. B., Schwartz R. S. Familial abnormalities of suppressor cell function in systemic lupus erythematosus. N. Engl. J. Med. 1979; 301: 803
   PubMed Web of Science ®Google Scholar
• Sakane T., Green I. Human suppressor T cells induced by concanavalin A: suppressor T cells belong to distinctive T cell subclasses. J. Immunol. 1977; 119: 1169
   PubMedGoogle Scholar
• Laughter A. H., Twomey J. J. Suppression of lymphoproliferation by high concentrations of normal human mononuclear leukocytes. J. Immunol. 1977; 119: 173
   PubMed Web of Science ®Google Scholar
• Chisari F. V., Anderson D. S. Cytotoxic and suppressor cell function in hepatitis. Clin. Res. 1979; 27: 470A
   Google Scholar
• Wands J. R., Perrotto J. L., Alpert E., Isselbacher F. J. Cell-mediated immunity in acute and chronic hepatitis. J. Clin. Invest. 1975; 55: 921
   PubMed Web of Science ®Google Scholar
• El Sheikh N., Osman C. G., Cullens H., Eddleston A. L. W. F., Williams R. T lymphocyte-mediated cytotoxicity in HBsAg positive liver disease. Clin. Exp. Immunol. 1978; 31: 158
   PubMedGoogle Scholar
• Vogten A. J. M., Hadzic N., Shorter R. G., Summerskill W. H. J., Taylor W. F. Cell-mediated cytotoxicity in chronic active liver disease: a new test system. Gastroenterology 1978; 74: 883
   PubMedGoogle Scholar
• Wands J. R., Perrotto J. L., Alpert E., Isselbacher K. J. Cell-mediated immunity in acute and chronic hepatitis. J. Clin. Invest. 1975; 55: 921
   PubMed Web of Science ®Google Scholar
• Alberti A., Realdi G., Bortolotti F., Rigoli A. M. T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis B virus infection. Gut 1977; 18: 1004
   PubMedGoogle Scholar
• Warnatz H., Rosch W., Gerlich W., Gutmann W. Antibody-dependent cell-mediated cytotoxicity to HBsAg coated target cells in patients with hepatitis B and chronic hepatitis (C A H). Clin. Exp. Immunol. 1979; 35: 133
   PubMedGoogle Scholar
• Chisari F. V., Bieber M. S., Josepho C. A., Xavier C., Anderson D. S. Functional properties of lymphocyte sub populations in hepatitis B virus infection. II. Cytotoxic effector cell killing of targets which naturally express hepatitis B surface antigen and liver specific lipoprotein. J. Immunol. 1981; 126: 45
   PubMedGoogle Scholar
• Vierling J. M., Nelson P. K., Strober W., Bundy B. M., Jones E. A. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis, dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis. J. Clin. Invest. 1977; 60: 1116
   PubMedGoogle Scholar
• Facchini A., Stefanni G. F., Bernardi M., Miglio F., Gasbarini G., Labo G. Lymphocyto-toxicity test against rabbit hepatocytes in chronic liver diseases. Gut 1978; 19: 189
   PubMedGoogle Scholar
• Alexander J. J., Bey E. M., Geddes E. W., Lecatsas G. Establishment of a continuous growing cell line from primary carcinoma of the liver. S. Afr. Med. J. 1976; 50: 2124
   PubMed Web of Science ®Google Scholar
• Chang R. S. Continuous subcultivation of epithelial-like cells from normal tissue. Proc. Soc. Exp. Biol. Med. 1954; 87: 440
   PubMed Web of Science ®Google Scholar
• Cochrane A. M. B., Moussouros A., Thomson A. D., Eddleston A. L. W. F., Williams R. Antibody dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis. Lancet 1976; 1: 441
   PubMed Web of Science ®Google Scholar
• Eddleston A. L. W. F., Williams R. The role of immunological mechanisms in chronic hepatitis. Ann. Clin. Res. 1976; 8: 162
   PubMedGoogle Scholar
• Williams R., Eddleston A. L. W. F. Chronic Active Hepatitis: immunopathogenesis and immunotherapy. Isr. J. Med. Set 1979; 15: 261
   PubMedGoogle Scholar
• Magnius L. O., Espmark J. A. New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J. Immunol. 1972; 109: 1017
   PubMed Web of Science ®Google Scholar
• Neurath A. R., Strick N. Host specificity of a serum marker for hepatitis B: evidence that “e antigen” has the properties of an immunoglobulin. Proc. Nat. Acad. Set 1977; 74: 1702
   PubMedGoogle Scholar
• Miyakawa Y., Mayumi M. Characterization and clinical significance of HBcAg. Viral Hepatitis, G. Vyas, S. N. Cohen, R. Schmid. The Franklin Institute Press, Philadelphia 1978; 193
   Google Scholar
• Alberti A., Realdi G., Tremolodi F., Spiver G. P. Liver cell surface localization of hepatitis B antigen and immunoglobulins in acute and chronic hepatitis and liver cirrhosis. Clin. Exp. Imunol. 1976; 25: 396
   PubMedGoogle Scholar
• Nowoslaski A., Krawczynski T., Nazarewicsz T., Scusarcyzk Y. Immunologic aspects of hepatitis B virus infection. Am. J. Med. Sci. 1975; 270: 229
   PubMedGoogle Scholar
• Redeker A. G. Viral hepatitis: clinical aspects. Am. J. Med. Sci. 1975; 270: 9
   PubMed Web of Science ®Google Scholar
• Meyer Zum Buschenfelde K. B., Meixcher P. A. Liver specific antigens. Purification and characterization. Clin. Exp. Immunol. 1972; 10: 89
   PubMed Web of Science ®Google Scholar
• McFarlane G., Wojcicka B. M., Zucker G. M., Eddleston A. L. W. F., Williams R. Purification and characterization of human liver-specific membrane lipoprotein (LSP). Clin. Exp. Immunol. 1977; 27: 381
   PubMed Web of Science ®Google Scholar
• Chisari F. V. Liver-specific protein in perspective. Gastroenterology 1979; 7: 168
   Google Scholar
• Behrens U. H., Paronetto F. Studies on liver-specific antigens. I. Evaluation of the liver specificity of “LSP” and “LP-2”. Gastroenterology 1979; 77: 1045
   PubMedGoogle Scholar
• Meyer Zum Buschenfelde K. H., Kossling F. K., Miescher P. A. Experimental chronic active hepatitis in rabbits following immunization with human liver proteins. Clin. Exp. Immunol. 1972; 10: 99
   Google Scholar
• Jensen D. M., McFarlane I. G., Portmann B. S., Eddleston A. L. W. F., Williams R. Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. New Engl. J. Med. 1978; 299: 1
   PubMed Web of Science ®Google Scholar
• Lee V. M., Reed W. D., Mitchell C. G., Galbraith R. M., Eddleston A. L. W. F., Zuckerman A. J., Williams R. W. Cellular and humoral immunity to hepatitis-B surface antigen in active chronic hepatitis. Br. Med. J. 1975; 1: 705
   PubMed Web of Science ®Google Scholar
• Sorrell M. F., Leevy C. M. Lymphocyte transformation and alcoholic liver injury. Gastroenterology 1972; 63: 1020
   PubMed Web of Science ®Google Scholar
• Meyer Zum Buschenfelde K. H., Alberti A., Arnold W. Freudenberg Organ specificity and dianostic value of cell mediated immunity against a liver-specific membrane protein: studies in hepatic and non-hepatic diseases. J. Klin. Wochenschr. 1975; 53: 1061
   PubMedGoogle Scholar
• Paronetto F., Vernace S. Immunological studies in patients with chronic active hepatitis. Clin. Exp. Immunol. 1975; 19: 99
   PubMed Web of Science ®Google Scholar
• Fernandez-Cruz E., Escartin P., Bootello A., Kreisler H., Segovia De Arana J. M. Hepatocyte damage induced by lymphocytes from patients with chronic liver diseases as detected by LDH release. Clin. Exp. Immunol. 1978; 31: 436
   PubMedGoogle Scholar
• Chisari F. V., Edgington T. S. Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein. J. Exp. Med. 1975; 142: 1092
   PubMed Web of Science ®Google Scholar
• Edgington T. S., Chisari F. V., Curtiss L. K. Regulation of lymphocyte function in HBV infection. Immunopathology International Symposium. Schwabe and Co. Publishers, Basel/Stuttgart 1976; 173, 190
   Google Scholar
• Edgington T. S., Curtiss L. K., DeHeer D. H. Immunoregulatory characteristics of LDL-In a species of normal low density lipoprotein. Clin. Res. 1976; 24: 445A
   Google Scholar
• Edgington T. S., Henney C. H., Curtiss L. K. The bioregulatory properties of the low density lipoprotein inhibitor (LDL-In) on the generation of killer T cells. Proc. 11th Leukocyte Culture Conference, P. A. Miescher. Schwabe and Co. Publishers, Basel/Stuttgart 1976; 173
   Google Scholar
• Chisari F. V. Regulation of human lymphocyte function by a soluble extract from normal human liver. J. Immunol. 1978; 121: 1279
   PubMed Web of Science ®Google Scholar
• Chisari F. V. Immunoregulatory properties of human plasma in very low density lipoprotein. J. Immunol. 1977; 119: 2129
   PubMedGoogle Scholar
• Mortensen R. F., Osmand A. P., Gewurz H. Effects of C. reactive protein on the lymphoid system. J. Exp. Med. 1975; 141: 821
   PubMedGoogle Scholar
• Charpentier B., Guttmann Shuster J., Gold P. Augmentation of proliferation of human mixed lymphocyte culture by human ã-fetoprotein. J. Immunol. 1977; 119: 897
   PubMedGoogle Scholar
• Girmann G., Pees H., Shwartze G., Scheurlen P. G. Immunosuppression by micromolecular fibrinogen degradation products in cancer. Nature 1976; 259: 399
   PubMedGoogle Scholar
• Tomasi T. B. Serum factors which suppress the immune response. Regulatory Mechanisms of Lymphocyte Activation, D. O. Lucas. Academic Press, New York 1977; 219
   Google Scholar
• Seidel D., Alaupovic P., Furman R. H. A lipoprotein characterizing obstructive jaundice, method for quantitative separation and identification of lipoproteins in jaundiced subjects. J. Clin. Invest. 1969; 48: 1211
   PubMed Web of Science ®Google Scholar
• Sell S., Skelly H., Leffert H. L., Mueller-Eberhard W., Kida S. Relationship of the biosynthesis of ã-fetoprotein, albumin, hemopexin, and hepatoglobin to the growth state of fetal rat hepatocyte cultures. Ann. M. Y. Acad. Sci. 1975; 259: 45
   PubMedGoogle Scholar
• Sabesin S. M., Koff R. S. Pathogenesis of experimental viral hepatitis. N. Engl. J. Med. 1974; 290: 944
   Google Scholar
• Bang F. B., Warwick A. Mouse macrophages as host cells for the mouse hepatitis virus and the genetic basis of their susceptibility. Proc. Nat. Acad. Sci. U.S.A. 1960; 46
   Google Scholar
• Shif I., Bang F. B. In vitro interaction of mouse hepatitis virus and macrophages from genetically resistant mice. I. Adsorption of virus and growth curves. J. Exp. Med. 1970; 131: 843
   PubMedGoogle Scholar
• Joseph B. S., Oldstone M. B. A. Antibody induced redistribution of measles virus antigens on the cell surface. J. Immunol. 1975; 113: 1205
   Google Scholar
• Steven J. G., Cook M. L. Maintenance of latent herpetic infection: an apparent role for anti-viral IgG. J. Immunol. 1974; 113: 1685
   PubMedGoogle Scholar